NDC product
Dibucaine Topical Anesthetic 1% Hemorrhoidal
NDC 0536-1211 · Rugby Laboratories Inc.
Key facts
| Product NDC | 0536-1211 |
|---|---|
| Proprietary name | Dibucaine Topical Anesthetic 1% Hemorrhoidal |
| Nonproprietary name | DIBUCAINE |
| Substances | DIBUCAINE |
| Dosage form | OINTMENT |
| Route | TOPICAL |
| Labeler | Rugby Laboratories Inc. |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M015 |
| Pharmacologic classes | Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC] |
| Marketing start | Aug 19, 2019 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: